Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Agdia is a private agricultural diagnostics company focused on plant pathogen and transgenic trait detection rather than human therapeutics. Founded in 1981 and headquartered in Elkhart, Indiana, the company develops and sells laboratory and field-based test kits for detection of plant viruses, bacteria, fungi, plant hormones, and GMO traits. Its product portfolio includes ELISA kits, ImmunoStrip lateral-flow tests, AmplifyRP molecular assays, PCR-based tests, nucleic acid hybridization products, and related custom assay development services. Agdia also operates an ISO-accredited testing services laboratory that receives plant samples from around the world. The business serves growers, breeders, propagators, universities, regulatory organizations, and private testing laboratories across global agricultural markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Agdia.